Navigation Links
Special Issue of PharmacoEconomics to Focus on Comparative Effectiveness Research
Date:9/22/2010

BRIDGEWATER, N.J., Sept. 22 /PRNewswire/ -- Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to the pharmaceutical and biotech fields, announced today that the Adis journal PharmacoEconomics has released a special issue devoted entirely to comparative effectiveness research (CER).  CER seeks to compare various medical interventions based on price, safety and effectiveness as a means to improve patient healthcare and slow the rise of healthcare costs.

CER has become increasingly relevant in light of U.S. healthcare reform as evidenced by President Obama recently signing into law a bill that establishes the Patient-Centered Outcomes Research Institute, a non-profit organization tasked with setting priorities and funding in this area.  In addition, more than $1.1 billion in federal funding was earmarked for CER as part of the American Recovery and Reinvestment Act (ARRA).

"CER is an important touchstone in this new era which puts more priority on patient-centered and cost-conscious approaches to healthcare," said Christopher Carswell, Editor of PharmacoEconomics.  "Our goal is to further raise awareness for this important area of research and set forth some of the best approaches for incorporating CER into the fabric of global healthcare."

Published today online, the special issue contains papers from thought leaders and key stakeholders from various constituencies around the globe including the pharmaceutical industry, pharmaceutical benefit managers (PBMs) managed care pharmacy and government and private payers from the U.S., Canada, Europe and the Pacific-Rim.  As guest editors for the issue, health economists Howard Birnbaum and Paul Greenberg of Analysis Group, Inc., a leading provider of economic, financial, and business expertise in the healthcare industry, collected a diverse set of opinions on this pressing topic—some of which are in opposition with each other.  The issue's primary aim:  to fuel more discussion about CER as a means to help continue its forward momentum in the future.

Organizations represented in the issue include the U.S.'s Agency for Healthcare Research and Quality (AHRQ) and Center for Medical Technology Policy (CMTP); the U.K.'s National Institute for Health and Clinical Excellence (NICE); the PBM Medco; Johnson & Johnson; and Eli Lilly and Company, among others.

The benchmark journal on the applications of pharmacoeconomics and quality-of-life assessment, PharmacoEconomics is an invaluable source of applied original research and educational material for the healthcare decision maker.  The peer-reviewed Adis journal is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization.

Available online now, the special issue devoted to CER will be published in the next PharmacoEconomics print edition, available by subscription in October.

For more information or to purchase PharmacoEconomics or any of the other peer-reviewed Adis publications, visit http://adisonline.com.  For additional information, visit the company's website at www.wolterskluwerpharma.com.

About Wolters Kluwer Pharma SolutionsWolters Kluwer Pharma Solutions, Inc. (Bridgewater, NJ) provides clinical and healthcare data and analytics, leading medical publishing services, and market intelligence tools to the pharmaceutical, biotech, and medical device fields. The company's brands include Adis, Source® and VisionCare Group. The global publisher Adis, provides peer-reviewed journals promoting rational pharmacology and effective patient management, and offers highly respected drug and clinical trials databases. A longstanding provider of market data and healthcare analytics, Source® offers a unique set of comprehensive patient and physician-level prescribing and usage data. VisionCare Group is a publisher of business and specialty publications and producer of conferences and e-media products targeting the vision market. For more information, visit www.wolterskluwerpharma.com.

The company is a wholly owned subsidiary of Wolters Kluwer, U.S., part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer has 2009 annual revenues of  euro 3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.

Visit our website, YouTube or follow @Wolters_Kluwer on Twitter for more information about our customers, market positions, brands, and organization.Contact:

Tom KivettKivett & Company Communications+1 212 727-2935tkivett@kivettandco.com
'/>"/>

SOURCE Wolters Kluwer Pharma Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Special Event Providing Exclusive Access to Shanghais Booming Zhangjiang Pharma Valley Added to Agenda of First Annual SBS China Conference
2. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
3. Diplomat Specialty Pharmacy Honored by Inc. Magazine as One of the Nations Fastest-Growing Companies
4. Former Singapore EDB Officer, Chew Hwee Yong, Joins Menicon as Chief of Special Projects as Menicon Accelerates its Globalization
5. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
6. Specialty Surgical Instrumentation Launches New Interactive Web Site
7. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
8. Specialty Pharma Association Announces Fall Conference
9. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
10. Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
11. In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
Breaking Medicine News(10 mins):